Skip to main content

View full-text article in PMC

. 2010 Mar 28;16(12):1458–1464. doi: 10.3748/wjg.v16.i12.1458

Table 3.

Effect of HYRD on serum levels of PCIII, HA, LN and CIV (mean ± SD)

Groups	PCIII (μg/mL)	HA (ng/mL)	LN (ng/mL)	CIV (ng/mL)
Control	15.16 ± 15.12^b	205.30 ± 48.92^a	82.02 ± 8.86	21.71 ± 1.76
Model	35.73 ± 17.90	563.82 ± 335.54	89.57 ± 7.59	29.20 ± 6.17
Low-dosage HYRD group	27.87 ± 10.13	464.19 ± 283.41	79.86 ± 9.52	26.38 ± 8.61
Medium-dosage HYRD group	24.72 ± 10.87^a	256.46 ± 95.98^b	86.34 ± 8.30	24.41 ± 4.46
High-dosage HYRD group	20.34 ± 13.92^b	161.51 ± 48.29^b	83.26 ± 13.20	26.22 ± 7.97

^a

P < 0.05,

^b

P < 0.01 vs model group. PCIII: Type III precollagen; HA: Hyaluronic acid; LN: Laminin; CIV: Type IV collagen.